Phase II study of nedaplatin plus docetaxel in patients with advanced squamous cell lung cancer pretreated with platinum-based chemotherapy.
Phase 2
Recruiting
- Conditions
- relapsed squamous cell lung cancer
- Registration Number
- JPRN-UMIN000003883
- Lead Sponsor
- Shizuoka Cancer Center, Thoracic Oncology Division
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 28
Inclusion Criteria
Not provided
Exclusion Criteria
1) interstitial pneumonia or pulmonary fibrosis detectable on CT scan 2) symptomatic brain metastasis 3) steroid treatment 4) massive pleural effusion or pericardial effusion 5) active infection 6) history of active double cancer 7) history of severe drug allergy 8) uncontrollable diabetes mellitus 9) HBs antigen 10) history of pregnancy or lactation 11) history of active psychological disease 12) severe drug allergy for 80 polysorbate content medicine 13) any other medical condition that makes the patient unsuitable for inclusion in the study according to the opinion of the investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method response rate
- Secondary Outcome Measures
Name Time Method overall survival, progression-free survival, adverse events